Organovo ONVO Stock
Organovo Price Chart
Organovo ONVO Financial and Trading Overview
| Organovo stock price | 2.17 USD |
| Previous Close | 1.94 USD |
| Open | 1.93 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 3200 |
| Day's Range | 1.81 - 1.93 USD |
| 52 Week Range | 1.37 - 3.72 USD |
| Volume | 26.14K USD |
| Avg. Volume | 25.12K USD |
| Market Cap | 15.77M USD |
| Beta (5Y Monthly) | 0.845774 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.08 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ONVO Valuation Measures
| Enterprise Value | -3074675 USD |
| Trailing P/E | N/A |
| Forward P/E | -8.619047 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.235016 |
| Price/Book (mrq) | 0.707584 |
| Enterprise Value/Revenue | -1.8 |
| Enterprise Value/EBITDA | 0.265 |
Trading Information
Organovo Stock Price History
| Beta (5Y Monthly) | 0.845774 |
| 52-Week Change | -3.72% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.72 USD |
| 52 Week Low | 1.37 USD |
| 50-Day Moving Average | 1.9 USD |
| 200-Day Moving Average | 1.9 USD |
ONVO Share Statistics
| Avg. Volume (3 month) | 25.12K USD |
| Avg. Daily Volume (10-Days) | 25.5K USD |
| Shares Outstanding | 8.71M |
| Float | 8.64M |
| Short Ratio | 21.76 |
| % Held by Insiders | 0.98% |
| % Held by Institutions | 13.90% |
| Shares Short | 441.24K |
| Short % of Float | 5.11% |
| Short % of Shares Outstanding | 5.05% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | March 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -694.67% |
| Gross Margin | -167.62% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -24.64% |
| Return on Equity (ttm) | -43.71% |
Income Statement
| Revenue (ttm) | 1.71M USD |
| Revenue Per Share (ttm) | 0.2 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -1820000 USD |
| EBITDA | -11585000 USD |
| Net Income Avi to Common (ttm) | -11711000 USD |
| Diluted EPS (ttm) | -1.38 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 20.75M USD |
| Total Cash Per Share (mrq) | 2.38 USD |
| Total Debt (mrq) | 1.9M USD |
| Total Debt/Equity (mrq) | 8.53 USD |
| Current Ratio (mrq) | 15.708 |
| Book Value Per Share (mrq) | 2.558 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9216000 USD |
| Levered Free Cash Flow (ttm) | -5323625 USD |
Profile of Organovo
| Country | United States |
| State | CA |
| City | Solana Beach |
| Address | 11555 Sorrento Valley Road |
| ZIP | 92121 |
| Phone | 858 224 1000 |
| Website | https://www.organovo.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.
Q&A For Organovo Stock
What is a current ONVO stock price?
Organovo ONVO stock price today per share is 2.17 USD.
How to purchase Organovo stock?
You can buy ONVO shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Organovo?
The stock symbol or ticker of Organovo is ONVO.
Which industry does the Organovo company belong to?
The Organovo industry is Biotechnology.
How many shares does Organovo have in circulation?
The max supply of Organovo shares is 1.8M.
What is Organovo Price to Earnings Ratio (PE Ratio)?
Organovo PE Ratio is now.
What was Organovo earnings per share over the trailing 12 months (TTM)?
Organovo EPS is -10.08 USD over the trailing 12 months.
Which sector does the Organovo company belong to?
The Organovo sector is Healthcare.
Organovo ONVO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16550.61 USD — |
-5.97
|
8.29B USD — | 16533.04 USD — | 16889.34 USD — | — - | 8.29B USD — |
| NASDAQ Capital Market Composite RCMP | 96.46 USD — |
-4.76
|
— — | 95.94 USD — | 97.68 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 920.53 USD — |
-2.33
|
— — | 917.85 USD — | 930.28 USD — | — - | — — |
- {{ link.label }} {{link}}